Clinical and Translational Research Center

The Clinical and Translational Research Center (CTRC) spearheads more than 700 cutting-edge clinical trials, spanning across 22 departments at any given time, and is the dedicated MD Anderson site for complex, biologically based new drug development. With its 41-bed treatment room nursing area and adjacent full-function laboratory, the 12,660 square foot facility is an ideal location to perform intensive clinical trials with a focus on first-in-man, Phase I and Phase II studies with rigorous time points and pharmacologic testing. The CTRC provides a unique resource for physician-scientists and clinical investigators to develop new agents for cancer treatment by offering coordination of multidisciplinary research, regulatory compliance, budget development, intensive and time-sensitive monitoring of patients, phlebotomy, prompt accurate specimen processing, storage, tracking and shipment of specimens.

Created in 1990 and now with 15,000 patient visits annually, the CTRC is one of the largest and most influential clinical trial facilities globally. A key pillar of the CTRC's success lies in the unwavering dedication of its nursing and laboratory staff, who undergo rigorous and specialized clinical research training, empowering them with the knowledge and skills to deliver the highest quality of care for our patients.